Inactive Instrument
Company Constellation Pharmaceuticals, Inc.
Stocks
CNST
US2103731061
Biotechnology & Medical Research
Business description: Constellation Pharmaceuticals, Inc.
Number of employees: 154
Sales by Activity: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Geographical breakdown of sales: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Executive Committee: Constellation Pharmaceuticals, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
John McKenna
PSD | President | - | - |
Kia Khalaghpour
IRC | Investor Relations Contact | - | - |
Irina Apostolou
PRN | Corporate Officer/Principal | - | 01/08/2016 |
Brenda J. Sousa
COO | Chief Operating Officer | 62 | 01/04/2017 |
Composition of the Board of Directors: Constellation Pharmaceuticals, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 15/07/2021 | |
John McKenna
BRD | Director/Board Member | - | - |
Company details: Constellation Pharmaceuticals, Inc.
Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.52% | -7.19% | +51.66% | +69.99% | 6.58TCr | |
| +1.37% | +9.32% | +11.97% | +86.00% | 5.19TCr | |
| +3.07% | +4.62% | +2.99% | +65.85% | 5.12TCr | |
| -0.38% | +1.40% | +29.98% | +42.37% | 4.38TCr | |
| +0.30% | +5.64% | +16.99% | +133.30% | 4.21TCr | |
| +2.35% | -6.08% | +236.69% | +528.10% | 3.9TCr | |
| +2.16% | +9.87% | +18.92% | +59.70% | 3.4TCr | |
| +3.84% | -2.34% | +39.18% | +8.57% | 2.52TCr | |
| +1.12% | +3.97% | +29.27% | +24.42% | 2.28TCr | |
| Average | +1.55% | +0.27% | +48.63% | +113.15% | 4.18TCr | |
| Weighted average by Cap. | +1.48% | +0.20% | +47.21% | +115.29% |
